-
Mashup Score: 1Current Issue – Gastroenterology & Hepatology - 2 month(s) ago
Abstract: Tremendous effort has been put forth over the past 2 decades in understanding the pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Although multiple potential […] Abstract: Barrett esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), a cancer that continues to have a poor 5-year survival rate of 20%. […] G & H What led to the concept of a treat-to-target approach for the management of patients with inflammatory bowel
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Reflecting on a Decade of Sofosbuvir Use for Hepatitis C Virus Treatment – Gastroenterology & Hepatology - 2 month(s) ago
Ira M. Jacobson, MD Professor of Medicine Director of Hepatology Research NYU Langone Health New York, New York G & H Sofosbuvir was approved with ribavirin or pegylated interferon plus ribavirin just over 10 years ago for the treatment of hepatitis C virus infection. Thinking back over the past decade of its use, why was sofosbuvir studied in this area in the first place? IJ Sofosbuvir is a nucleotide analog inhibitor of hepatitis C virus (HCV) NS5B polymerase. The drug mimics one of the normal building
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1Durvalumab Plus Tremelimumab for First-Line Treatment of Hepatocellular Carcinoma – Gastroenterology & Hepatology - 2 month(s) ago
Robin Kate Kelley, MD Professor of Clinical Medicine Division of Hematology/Oncology Helen Diller Family Comprehensive Cancer Center University of California, San Francisco San Francisco, California G & H What is the rationale for using durvalumab and tremelimumab in combination for the treatment of hepatocellular carcinoma? RK Durvalumab (Imfinzi, AstraZeneca) and tremelimumab (Imjudo, AstraZeneca) are both immune checkpoint inhibitors, but different ones. Durvalumab is an inhibitor of the programmed
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Reviewing Recommendations for Vaccines and Health Care Maintenance in Patients With Inflammatory Bowel Disease – Gastroenterology & Hepatology - 3 month(s) ago
Francis A. Farraye, MD, MSc Professor of Medicine Director, Inflammatory Bowel Disease Center Division of Gastroenterology and Hepatology Mayo Clinic Jacksonville, Florida G & H What are the current recommendations for influenza and respiratory syncytial virus vaccines in patients with inflammatory bowel disease? FF All patients with inflammatory bowel disease (IBD) should receive the inactive injectable annual influenza vaccine. There are 3 formulations (Flublok Quadrivalent, Protein Sciences Corporation;
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Esophagogastric Junction Outflow Obstruction: A Diagnosis in Evolution – Gastroenterology & Hepatology - 3 month(s) ago
Kristle Lee Lynch, MD Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania Joan Chen, MD, MS 2Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan Anand Jain, MD Division of Digestive Diseases, Emory University, Atlanta, Georgia Rena Yadlapati, MD Division of Gastroenterology and Hepatology, University of California San Diego, La Jolla, California Corresponding author: Dr Rena Yadlapati 9500 Gilman Drive, MC 0956 La
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 3
Aalam Sohal, MD Liver Institute Northwest, Seattle, Washington Kris V. Kowdley, MD Liver Institute Northwest, Seattle, Washington Elson S. Floyd College of Medicine, Washington State University, Spokane, Washington Corresponding author: Dr Kris V. Kowdley Liver Institute Northwest 3216 NE 45th Place, Suite 212 Seattle, WA 98105 Tel: (206) 536-3030 Fax: (844) 273-1244 E-mail: kkowdley@liverinstitutenw.org Abstract: Iron overload disorders are conditions that can lead to increased body iron stores and
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy – Gastroenterology & Hepatology - 3 month(s) ago
Trevor L. Schell, MD Department of Internal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin Freddy Caldera, DO, MS Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin Corresponding author: Dr Freddy Caldera 1685 Highland Avenue Madison, WI 53705-2281 Tel: (608) 263-1995 Fax: (608) 265-5677 E-mail: fcaldera@medicine.wisc.edu Abstract: The COVID-19 pandemic
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1Current Issue – Gastroenterology & Hepatology - 3 month(s) ago
Abstract: Tremendous effort has been put forth over the past 2 decades in understanding the pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Although multiple potential […] Abstract: Barrett esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), a cancer that continues to have a poor 5-year survival rate of 20%. […] G & H What led to the concept of a treat-to-target approach for the management of patients with inflammatory bowel
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0
“Potassium-Competitive Acid Blockers and Gastroesophageal Reflux Disease” with David Armstrong, MA, MB BChir… https://t.co/YawOvRycG4 “Examining the New Definition of Hepatorenal Syndrome and the Role of Terlipressin” with Robert S. Brown Jr, MD, MPH https://t.co/ETH9dEBCqq
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 7Highlights From the ACG Guidelines for Acute Liver Failure – Gastroenterology & Hepatology - 4 month(s) ago
Alexandra Shingina, MD, MS Associate Professor of Medicine Vanderbilt University Medical Center Nashville, Tennessee G & H Why were guidelines recently released for acute liver failure? AS The previous North American guidelines on acute liver failure had been released over a decade ago from the American Association for the Study of Liver Diseases, so there was a need to review the updated literature on this disease since then. The goal was to incorporate recent advances in the medical field and how they
Categories: General Medicine News, GastroenterologyTweet
The latest issue of Gastroenterology & Hepatology is now available online https://t.co/GtoiDSlzRi #gastroenterology #hepatology